开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2207167, encodeId=8650220e1672f, content=投稿链接是什么，为啥我打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28bc9231086, createdName=ms5000000002868146, createdTime=Tue May 28 22:44:38 CST 2024, time=2024-05-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180130, encodeId=bbb8218013085, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一篇新化合物+药理学研究的稿子，从投稿到接收共三个月，审稿很快。因审稿人问的问题非常专业，回复+补充数据时间花费了一个半月左右。还经历了二修，也修改了整整一个星期，这再次提升了我们稿子的质量，非常感谢这么专业的审稿人。二修返回第二天立马接收，效率杠杠的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Mon Jan 08 22:11:23 CST 2024, time=2024-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173349, encodeId=557321e3349b0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：药理学 经验分享：10分钟秒拒哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85938247141, createdName=ms2000002084293332, createdTime=Wed Dec 06 20:00:30 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560071, encodeId=0c8c5600e1c1, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：一篇新化合物+药理的稿子，觉得投欧洲药理，有点亏。就试了EJPS，从投稿到接收4个多月，审稿人很专业，我服气。总体感觉杂志很不错，绝对不是水刊，想灌水的可能到时会浪费时间。编辑友好！值得推荐给真才实学的人投稿！祝福大家，好运！我争取以后每中一篇文章就来medsci写个评论！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAxm7OEiaSP1WjupgrcWiaiaibFaianxnw9HpHMWSn1Sicd1LA4QLxCMZsMgFianicX32fDCTtJdeyjuWBLg/132, createdBy=b6d02007865, createdName=Dr. Du, createdTime=Mon Aug 13 18:45:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127214, encodeId=2b75212e21430, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：纳米递送系统;动物实验;牙周炎 经验分享：开始投的Int J Pharmaceutics，被transfer到EJPS，前期审稿速度有点慢，8周将近2个月才返回一审意见，两个评审人提了很多问题，一一回答，还驳斥了一条建议（现在想想自己胆子真大），好在退修后速度就一路做火箭，从退修给编辑再到录用见刊2周完成。还是很推荐认真做实验的硕博士投稿的，主编很nice，虽然影响因子一般，但医学2区还是很值，祝大家投稿顺利，成果早日发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5102337243, createdName=12282116m72暂无昵称, createdTime=Thu Apr 20 10:13:58 CST 2023, time=2023-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=528171, encodeId=4cfb5281e11b, content=审稿意见回来了吗？大卫的 2016-09-13 发表:: 研究方向：药代动力学;; 刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, beContent=大卫的 2016-09-13 发表:: 研究方向：药代动力学;; 刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Thu Oct 13 08:41:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536798, encodeId=80ac536e983f, content=投稿命中率:50.0 经验分享：刚被接受了一篇，就是第一次审稿的时候，耽误了太多时间，中间询问过一次。审稿结束后，几个小时就给了修改的决定。改后再次审稿后，又改了一次，就一个问题。投回去后，几个小时就接受了，这个杂志online速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2571742971, createdName=JYUZ, createdTime=Wed May 17 10:53:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563173, encodeId=3e555631e3ff, content=没有版面费173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗？谢谢, beContent=173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Wed Nov 14 00:00:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858485, encodeId=7fee85848558, content=从刚投稿到一审结束总共花了3个半月，提了不少问题，花了将近一个月修改返回，然后审稿花了一个月接收，从投到在线总共花了差不多半年。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Tue Mar 17 13:17:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222775, encodeId=bb4c1222e750c, content=一修的时候更换的共同一作中的一个，直接因更换作者被拒了，还有救吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cdf5458328, createdName=金鱼的眼泪, createdTime=Fri May 27 12:12:31 CST 2022, time=2022-05-27, status=1, ipAttribution=)]

2024-05-28 ms5000000002868146 来自北京

投稿链接是什么，为啥我打不开

89 0

[GetPortalCommentsPageByObjectIdResponse(id=2207167, encodeId=8650220e1672f, content=投稿链接是什么，为啥我打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28bc9231086, createdName=ms5000000002868146, createdTime=Tue May 28 22:44:38 CST 2024, time=2024-05-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180130, encodeId=bbb8218013085, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一篇新化合物+药理学研究的稿子，从投稿到接收共三个月，审稿很快。因审稿人问的问题非常专业，回复+补充数据时间花费了一个半月左右。还经历了二修，也修改了整整一个星期，这再次提升了我们稿子的质量，非常感谢这么专业的审稿人。二修返回第二天立马接收，效率杠杠的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Mon Jan 08 22:11:23 CST 2024, time=2024-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173349, encodeId=557321e3349b0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：药理学 经验分享：10分钟秒拒哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85938247141, createdName=ms2000002084293332, createdTime=Wed Dec 06 20:00:30 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560071, encodeId=0c8c5600e1c1, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：一篇新化合物+药理的稿子，觉得投欧洲药理，有点亏。就试了EJPS，从投稿到接收4个多月，审稿人很专业，我服气。总体感觉杂志很不错，绝对不是水刊，想灌水的可能到时会浪费时间。编辑友好！值得推荐给真才实学的人投稿！祝福大家，好运！我争取以后每中一篇文章就来medsci写个评论！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAxm7OEiaSP1WjupgrcWiaiaibFaianxnw9HpHMWSn1Sicd1LA4QLxCMZsMgFianicX32fDCTtJdeyjuWBLg/132, createdBy=b6d02007865, createdName=Dr. Du, createdTime=Mon Aug 13 18:45:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127214, encodeId=2b75212e21430, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：纳米递送系统;动物实验;牙周炎 经验分享：开始投的Int J Pharmaceutics，被transfer到EJPS，前期审稿速度有点慢，8周将近2个月才返回一审意见，两个评审人提了很多问题，一一回答，还驳斥了一条建议（现在想想自己胆子真大），好在退修后速度就一路做火箭，从退修给编辑再到录用见刊2周完成。还是很推荐认真做实验的硕博士投稿的，主编很nice，虽然影响因子一般，但医学2区还是很值，祝大家投稿顺利，成果早日发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5102337243, createdName=12282116m72暂无昵称, createdTime=Thu Apr 20 10:13:58 CST 2023, time=2023-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=528171, encodeId=4cfb5281e11b, content=审稿意见回来了吗？大卫的 2016-09-13 发表:: 研究方向：药代动力学;; 刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, beContent=大卫的 2016-09-13 发表:: 研究方向：药代动力学;; 刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Thu Oct 13 08:41:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536798, encodeId=80ac536e983f, content=投稿命中率:50.0 经验分享：刚被接受了一篇，就是第一次审稿的时候，耽误了太多时间，中间询问过一次。审稿结束后，几个小时就给了修改的决定。改后再次审稿后，又改了一次，就一个问题。投回去后，几个小时就接受了，这个杂志online速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2571742971, createdName=JYUZ, createdTime=Wed May 17 10:53:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563173, encodeId=3e555631e3ff, content=没有版面费173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗？谢谢, beContent=173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Wed Nov 14 00:00:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858485, encodeId=7fee85848558, content=从刚投稿到一审结束总共花了3个半月，提了不少问题，花了将近一个月修改返回，然后审稿花了一个月接收，从投到在线总共花了差不多半年。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Tue Mar 17 13:17:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222775, encodeId=bb4c1222e750c, content=一修的时候更换的共同一作中的一个，直接因更换作者被拒了，还有救吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cdf5458328, createdName=金鱼的眼泪, createdTime=Fri May 27 12:12:31 CST 2022, time=2022-05-27, status=1, ipAttribution=)]

2024-01-08 ms9000001976206462 来自广东省

审稿速度:3.0 | 投稿命中率:50.0
经验分享：一篇新化合物+药理学研究的稿子，从投稿到接收共三个月，审稿很快。因审稿人问的问题非常专业，回复+补充数据时间花费了一个半月左右。还经历了二修，也修改了整整一个星期，这再次提升了我们稿子的质量，非常感谢这么专业的审稿人。二修返回第二天立马接收，效率杠杠的。

129 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207167, encodeId=8650220e1672f, content=投稿链接是什么，为啥我打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28bc9231086, createdName=ms5000000002868146, createdTime=Tue May 28 22:44:38 CST 2024, time=2024-05-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180130, encodeId=bbb8218013085, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一篇新化合物+药理学研究的稿子，从投稿到接收共三个月，审稿很快。因审稿人问的问题非常专业，回复+补充数据时间花费了一个半月左右。还经历了二修，也修改了整整一个星期，这再次提升了我们稿子的质量，非常感谢这么专业的审稿人。二修返回第二天立马接收，效率杠杠的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Mon Jan 08 22:11:23 CST 2024, time=2024-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173349, encodeId=557321e3349b0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：药理学 经验分享：10分钟秒拒哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85938247141, createdName=ms2000002084293332, createdTime=Wed Dec 06 20:00:30 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560071, encodeId=0c8c5600e1c1, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：一篇新化合物+药理的稿子，觉得投欧洲药理，有点亏。就试了EJPS，从投稿到接收4个多月，审稿人很专业，我服气。总体感觉杂志很不错，绝对不是水刊，想灌水的可能到时会浪费时间。编辑友好！值得推荐给真才实学的人投稿！祝福大家，好运！我争取以后每中一篇文章就来medsci写个评论！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAxm7OEiaSP1WjupgrcWiaiaibFaianxnw9HpHMWSn1Sicd1LA4QLxCMZsMgFianicX32fDCTtJdeyjuWBLg/132, createdBy=b6d02007865, createdName=Dr. Du, createdTime=Mon Aug 13 18:45:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127214, encodeId=2b75212e21430, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：纳米递送系统;动物实验;牙周炎 经验分享：开始投的Int J Pharmaceutics，被transfer到EJPS，前期审稿速度有点慢，8周将近2个月才返回一审意见，两个评审人提了很多问题，一一回答，还驳斥了一条建议（现在想想自己胆子真大），好在退修后速度就一路做火箭，从退修给编辑再到录用见刊2周完成。还是很推荐认真做实验的硕博士投稿的，主编很nice，虽然影响因子一般，但医学2区还是很值，祝大家投稿顺利，成果早日发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5102337243, createdName=12282116m72暂无昵称, createdTime=Thu Apr 20 10:13:58 CST 2023, time=2023-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=528171, encodeId=4cfb5281e11b, content=审稿意见回来了吗？大卫的 2016-09-13 发表:: 研究方向：药代动力学;; 刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, beContent=大卫的 2016-09-13 发表:: 研究方向：药代动力学;; 刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Thu Oct 13 08:41:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536798, encodeId=80ac536e983f, content=投稿命中率:50.0 经验分享：刚被接受了一篇，就是第一次审稿的时候，耽误了太多时间，中间询问过一次。审稿结束后，几个小时就给了修改的决定。改后再次审稿后，又改了一次，就一个问题。投回去后，几个小时就接受了，这个杂志online速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2571742971, createdName=JYUZ, createdTime=Wed May 17 10:53:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563173, encodeId=3e555631e3ff, content=没有版面费173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗？谢谢, beContent=173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Wed Nov 14 00:00:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858485, encodeId=7fee85848558, content=从刚投稿到一审结束总共花了3个半月，提了不少问题，花了将近一个月修改返回，然后审稿花了一个月接收，从投到在线总共花了差不多半年。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Tue Mar 17 13:17:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222775, encodeId=bb4c1222e750c, content=一修的时候更换的共同一作中的一个，直接因更换作者被拒了，还有救吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cdf5458328, createdName=金鱼的眼泪, createdTime=Fri May 27 12:12:31 CST 2022, time=2022-05-27, status=1, ipAttribution=)]

2023-12-06 ms2000002084293332 来自甘肃省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：药理学
经验分享：10分钟秒拒哭了

117 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207167, encodeId=8650220e1672f, content=投稿链接是什么，为啥我打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28bc9231086, createdName=ms5000000002868146, createdTime=Tue May 28 22:44:38 CST 2024, time=2024-05-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180130, encodeId=bbb8218013085, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一篇新化合物+药理学研究的稿子，从投稿到接收共三个月，审稿很快。因审稿人问的问题非常专业，回复+补充数据时间花费了一个半月左右。还经历了二修，也修改了整整一个星期，这再次提升了我们稿子的质量，非常感谢这么专业的审稿人。二修返回第二天立马接收，效率杠杠的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Mon Jan 08 22:11:23 CST 2024, time=2024-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173349, encodeId=557321e3349b0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：药理学 经验分享：10分钟秒拒哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85938247141, createdName=ms2000002084293332, createdTime=Wed Dec 06 20:00:30 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560071, encodeId=0c8c5600e1c1, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：一篇新化合物+药理的稿子，觉得投欧洲药理，有点亏。就试了EJPS，从投稿到接收4个多月，审稿人很专业，我服气。总体感觉杂志很不错，绝对不是水刊，想灌水的可能到时会浪费时间。编辑友好！值得推荐给真才实学的人投稿！祝福大家，好运！我争取以后每中一篇文章就来medsci写个评论！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAxm7OEiaSP1WjupgrcWiaiaibFaianxnw9HpHMWSn1Sicd1LA4QLxCMZsMgFianicX32fDCTtJdeyjuWBLg/132, createdBy=b6d02007865, createdName=Dr. Du, createdTime=Mon Aug 13 18:45:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127214, encodeId=2b75212e21430, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：纳米递送系统;动物实验;牙周炎 经验分享：开始投的Int J Pharmaceutics，被transfer到EJPS，前期审稿速度有点慢，8周将近2个月才返回一审意见，两个评审人提了很多问题，一一回答，还驳斥了一条建议（现在想想自己胆子真大），好在退修后速度就一路做火箭，从退修给编辑再到录用见刊2周完成。还是很推荐认真做实验的硕博士投稿的，主编很nice，虽然影响因子一般，但医学2区还是很值，祝大家投稿顺利，成果早日发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5102337243, createdName=12282116m72暂无昵称, createdTime=Thu Apr 20 10:13:58 CST 2023, time=2023-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=528171, encodeId=4cfb5281e11b, content=审稿意见回来了吗？大卫的 2016-09-13 发表:: 研究方向：药代动力学;; 刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, beContent=大卫的 2016-09-13 发表:: 研究方向：药代动力学;; 刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Thu Oct 13 08:41:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536798, encodeId=80ac536e983f, content=投稿命中率:50.0 经验分享：刚被接受了一篇，就是第一次审稿的时候，耽误了太多时间，中间询问过一次。审稿结束后，几个小时就给了修改的决定。改后再次审稿后，又改了一次，就一个问题。投回去后，几个小时就接受了，这个杂志online速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2571742971, createdName=JYUZ, createdTime=Wed May 17 10:53:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563173, encodeId=3e555631e3ff, content=没有版面费173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗？谢谢, beContent=173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Wed Nov 14 00:00:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858485, encodeId=7fee85848558, content=从刚投稿到一审结束总共花了3个半月，提了不少问题，花了将近一个月修改返回，然后审稿花了一个月接收，从投到在线总共花了差不多半年。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Tue Mar 17 13:17:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222775, encodeId=bb4c1222e750c, content=一修的时候更换的共同一作中的一个，直接因更换作者被拒了，还有救吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cdf5458328, createdName=金鱼的眼泪, createdTime=Fri May 27 12:12:31 CST 2022, time=2022-05-27, status=1, ipAttribution=)]

2018-08-13 Dr. Du

审稿速度:2.0 | 投稿命中率:25.0
经验分享：一篇新化合物+药理的稿子，觉得投欧洲药理，有点亏。就试了EJPS，从投稿到接收4个多月，审稿人很专业，我服气。总体感觉杂志很不错，绝对不是水刊，想灌水的可能到时会浪费时间。编辑友好！值得推荐给真才实学的人投稿！祝福大家，好运！我争取以后每中一篇文章就来medsci写个评论！

341 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207167, encodeId=8650220e1672f, content=投稿链接是什么，为啥我打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28bc9231086, createdName=ms5000000002868146, createdTime=Tue May 28 22:44:38 CST 2024, time=2024-05-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180130, encodeId=bbb8218013085, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一篇新化合物+药理学研究的稿子，从投稿到接收共三个月，审稿很快。因审稿人问的问题非常专业，回复+补充数据时间花费了一个半月左右。还经历了二修，也修改了整整一个星期，这再次提升了我们稿子的质量，非常感谢这么专业的审稿人。二修返回第二天立马接收，效率杠杠的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Mon Jan 08 22:11:23 CST 2024, time=2024-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173349, encodeId=557321e3349b0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：药理学 经验分享：10分钟秒拒哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85938247141, createdName=ms2000002084293332, createdTime=Wed Dec 06 20:00:30 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560071, encodeId=0c8c5600e1c1, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：一篇新化合物+药理的稿子，觉得投欧洲药理，有点亏。就试了EJPS，从投稿到接收4个多月，审稿人很专业，我服气。总体感觉杂志很不错，绝对不是水刊，想灌水的可能到时会浪费时间。编辑友好！值得推荐给真才实学的人投稿！祝福大家，好运！我争取以后每中一篇文章就来medsci写个评论！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAxm7OEiaSP1WjupgrcWiaiaibFaianxnw9HpHMWSn1Sicd1LA4QLxCMZsMgFianicX32fDCTtJdeyjuWBLg/132, createdBy=b6d02007865, createdName=Dr. Du, createdTime=Mon Aug 13 18:45:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127214, encodeId=2b75212e21430, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：纳米递送系统;动物实验;牙周炎 经验分享：开始投的Int J Pharmaceutics，被transfer到EJPS，前期审稿速度有点慢，8周将近2个月才返回一审意见，两个评审人提了很多问题，一一回答，还驳斥了一条建议（现在想想自己胆子真大），好在退修后速度就一路做火箭，从退修给编辑再到录用见刊2周完成。还是很推荐认真做实验的硕博士投稿的，主编很nice，虽然影响因子一般，但医学2区还是很值，祝大家投稿顺利，成果早日发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5102337243, createdName=12282116m72暂无昵称, createdTime=Thu Apr 20 10:13:58 CST 2023, time=2023-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=528171, encodeId=4cfb5281e11b, content=审稿意见回来了吗？大卫的 2016-09-13 发表:: 研究方向：药代动力学;; 刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, beContent=大卫的 2016-09-13 发表:: 研究方向：药代动力学;; 刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Thu Oct 13 08:41:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536798, encodeId=80ac536e983f, content=投稿命中率:50.0 经验分享：刚被接受了一篇，就是第一次审稿的时候，耽误了太多时间，中间询问过一次。审稿结束后，几个小时就给了修改的决定。改后再次审稿后，又改了一次，就一个问题。投回去后，几个小时就接受了，这个杂志online速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2571742971, createdName=JYUZ, createdTime=Wed May 17 10:53:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563173, encodeId=3e555631e3ff, content=没有版面费173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗？谢谢, beContent=173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Wed Nov 14 00:00:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858485, encodeId=7fee85848558, content=从刚投稿到一审结束总共花了3个半月，提了不少问题，花了将近一个月修改返回，然后审稿花了一个月接收，从投到在线总共花了差不多半年。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Tue Mar 17 13:17:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222775, encodeId=bb4c1222e750c, content=一修的时候更换的共同一作中的一个，直接因更换作者被拒了，还有救吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cdf5458328, createdName=金鱼的眼泪, createdTime=Fri May 27 12:12:31 CST 2022, time=2022-05-27, status=1, ipAttribution=)]

2023-04-20 12282116m72暂无昵称来自上海

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：纳米递送系统;动物实验;牙周炎
经验分享：开始投的Int J Pharmaceutics，被transfer到EJPS，前期审稿速度有点慢，8周将近2个月才返回一审意见，两个评审人提了很多问题，一一回答，还驳斥了一条建议（现在想想自己胆子真大），好在退修后速度就一路做火箭，从退修给编辑再到录用见刊2周完成。还是很推荐认真做实验的硕博士投稿的，主编很nice，虽然影响因子一般，但医学2区还是很值，祝大家投稿顺利，成果早日发表

132 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207167, encodeId=8650220e1672f, content=投稿链接是什么，为啥我打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28bc9231086, createdName=ms5000000002868146, createdTime=Tue May 28 22:44:38 CST 2024, time=2024-05-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180130, encodeId=bbb8218013085, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一篇新化合物+药理学研究的稿子，从投稿到接收共三个月，审稿很快。因审稿人问的问题非常专业，回复+补充数据时间花费了一个半月左右。还经历了二修，也修改了整整一个星期，这再次提升了我们稿子的质量，非常感谢这么专业的审稿人。二修返回第二天立马接收，效率杠杠的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Mon Jan 08 22:11:23 CST 2024, time=2024-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173349, encodeId=557321e3349b0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：药理学 经验分享：10分钟秒拒哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85938247141, createdName=ms2000002084293332, createdTime=Wed Dec 06 20:00:30 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560071, encodeId=0c8c5600e1c1, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：一篇新化合物+药理的稿子，觉得投欧洲药理，有点亏。就试了EJPS，从投稿到接收4个多月，审稿人很专业，我服气。总体感觉杂志很不错，绝对不是水刊，想灌水的可能到时会浪费时间。编辑友好！值得推荐给真才实学的人投稿！祝福大家，好运！我争取以后每中一篇文章就来medsci写个评论！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAxm7OEiaSP1WjupgrcWiaiaibFaianxnw9HpHMWSn1Sicd1LA4QLxCMZsMgFianicX32fDCTtJdeyjuWBLg/132, createdBy=b6d02007865, createdName=Dr. Du, createdTime=Mon Aug 13 18:45:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127214, encodeId=2b75212e21430, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：纳米递送系统;动物实验;牙周炎 经验分享：开始投的Int J Pharmaceutics，被transfer到EJPS，前期审稿速度有点慢，8周将近2个月才返回一审意见，两个评审人提了很多问题，一一回答，还驳斥了一条建议（现在想想自己胆子真大），好在退修后速度就一路做火箭，从退修给编辑再到录用见刊2周完成。还是很推荐认真做实验的硕博士投稿的，主编很nice，虽然影响因子一般，但医学2区还是很值，祝大家投稿顺利，成果早日发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5102337243, createdName=12282116m72暂无昵称, createdTime=Thu Apr 20 10:13:58 CST 2023, time=2023-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=528171, encodeId=4cfb5281e11b, content=审稿意见回来了吗？大卫的 2016-09-13 发表:: 研究方向：药代动力学;; 刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, beContent=大卫的 2016-09-13 发表:: 研究方向：药代动力学;; 刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Thu Oct 13 08:41:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536798, encodeId=80ac536e983f, content=投稿命中率:50.0 经验分享：刚被接受了一篇，就是第一次审稿的时候，耽误了太多时间，中间询问过一次。审稿结束后，几个小时就给了修改的决定。改后再次审稿后，又改了一次，就一个问题。投回去后，几个小时就接受了，这个杂志online速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2571742971, createdName=JYUZ, createdTime=Wed May 17 10:53:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563173, encodeId=3e555631e3ff, content=没有版面费173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗？谢谢, beContent=173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Wed Nov 14 00:00:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858485, encodeId=7fee85848558, content=从刚投稿到一审结束总共花了3个半月，提了不少问题，花了将近一个月修改返回，然后审稿花了一个月接收，从投到在线总共花了差不多半年。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Tue Mar 17 13:17:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222775, encodeId=bb4c1222e750c, content=一修的时候更换的共同一作中的一个，直接因更换作者被拒了，还有救吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cdf5458328, createdName=金鱼的眼泪, createdTime=Fri May 27 12:12:31 CST 2022, time=2022-05-27, status=1, ipAttribution=)]

2016-10-13 yelinghao215

审稿意见回来了吗？大卫的 2016-09-13 发表::
研究方向：药代动力学;; 刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收

大卫的 2016-09-13 发表:: 研究方向：药代动力学;; 刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收

511 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207167, encodeId=8650220e1672f, content=投稿链接是什么，为啥我打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28bc9231086, createdName=ms5000000002868146, createdTime=Tue May 28 22:44:38 CST 2024, time=2024-05-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180130, encodeId=bbb8218013085, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一篇新化合物+药理学研究的稿子，从投稿到接收共三个月，审稿很快。因审稿人问的问题非常专业，回复+补充数据时间花费了一个半月左右。还经历了二修，也修改了整整一个星期，这再次提升了我们稿子的质量，非常感谢这么专业的审稿人。二修返回第二天立马接收，效率杠杠的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Mon Jan 08 22:11:23 CST 2024, time=2024-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173349, encodeId=557321e3349b0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：药理学 经验分享：10分钟秒拒哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85938247141, createdName=ms2000002084293332, createdTime=Wed Dec 06 20:00:30 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560071, encodeId=0c8c5600e1c1, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：一篇新化合物+药理的稿子，觉得投欧洲药理，有点亏。就试了EJPS，从投稿到接收4个多月，审稿人很专业，我服气。总体感觉杂志很不错，绝对不是水刊，想灌水的可能到时会浪费时间。编辑友好！值得推荐给真才实学的人投稿！祝福大家，好运！我争取以后每中一篇文章就来medsci写个评论！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAxm7OEiaSP1WjupgrcWiaiaibFaianxnw9HpHMWSn1Sicd1LA4QLxCMZsMgFianicX32fDCTtJdeyjuWBLg/132, createdBy=b6d02007865, createdName=Dr. Du, createdTime=Mon Aug 13 18:45:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127214, encodeId=2b75212e21430, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：纳米递送系统;动物实验;牙周炎 经验分享：开始投的Int J Pharmaceutics，被transfer到EJPS，前期审稿速度有点慢，8周将近2个月才返回一审意见，两个评审人提了很多问题，一一回答，还驳斥了一条建议（现在想想自己胆子真大），好在退修后速度就一路做火箭，从退修给编辑再到录用见刊2周完成。还是很推荐认真做实验的硕博士投稿的，主编很nice，虽然影响因子一般，但医学2区还是很值，祝大家投稿顺利，成果早日发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5102337243, createdName=12282116m72暂无昵称, createdTime=Thu Apr 20 10:13:58 CST 2023, time=2023-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=528171, encodeId=4cfb5281e11b, content=审稿意见回来了吗？大卫的 2016-09-13 发表:: 研究方向：药代动力学;; 刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, beContent=大卫的 2016-09-13 发表:: 研究方向：药代动力学;; 刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Thu Oct 13 08:41:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536798, encodeId=80ac536e983f, content=投稿命中率:50.0 经验分享：刚被接受了一篇，就是第一次审稿的时候，耽误了太多时间，中间询问过一次。审稿结束后，几个小时就给了修改的决定。改后再次审稿后，又改了一次，就一个问题。投回去后，几个小时就接受了，这个杂志online速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2571742971, createdName=JYUZ, createdTime=Wed May 17 10:53:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563173, encodeId=3e555631e3ff, content=没有版面费173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗？谢谢, beContent=173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Wed Nov 14 00:00:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858485, encodeId=7fee85848558, content=从刚投稿到一审结束总共花了3个半月，提了不少问题，花了将近一个月修改返回，然后审稿花了一个月接收，从投到在线总共花了差不多半年。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Tue Mar 17 13:17:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222775, encodeId=bb4c1222e750c, content=一修的时候更换的共同一作中的一个，直接因更换作者被拒了，还有救吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cdf5458328, createdName=金鱼的眼泪, createdTime=Fri May 27 12:12:31 CST 2022, time=2022-05-27, status=1, ipAttribution=)]

2017-05-17 JYUZ

投稿命中率:50.0
经验分享：刚被接受了一篇，就是第一次审稿的时候，耽误了太多时间，中间询问过一次。审稿结束后，几个小时就给了修改的决定。改后再次审稿后，又改了一次，就一个问题。投回去后，几个小时就接受了，这个杂志online速度很快。

432 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207167, encodeId=8650220e1672f, content=投稿链接是什么，为啥我打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28bc9231086, createdName=ms5000000002868146, createdTime=Tue May 28 22:44:38 CST 2024, time=2024-05-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180130, encodeId=bbb8218013085, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一篇新化合物+药理学研究的稿子，从投稿到接收共三个月，审稿很快。因审稿人问的问题非常专业，回复+补充数据时间花费了一个半月左右。还经历了二修，也修改了整整一个星期，这再次提升了我们稿子的质量，非常感谢这么专业的审稿人。二修返回第二天立马接收，效率杠杠的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Mon Jan 08 22:11:23 CST 2024, time=2024-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173349, encodeId=557321e3349b0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：药理学 经验分享：10分钟秒拒哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85938247141, createdName=ms2000002084293332, createdTime=Wed Dec 06 20:00:30 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560071, encodeId=0c8c5600e1c1, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：一篇新化合物+药理的稿子，觉得投欧洲药理，有点亏。就试了EJPS，从投稿到接收4个多月，审稿人很专业，我服气。总体感觉杂志很不错，绝对不是水刊，想灌水的可能到时会浪费时间。编辑友好！值得推荐给真才实学的人投稿！祝福大家，好运！我争取以后每中一篇文章就来medsci写个评论！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAxm7OEiaSP1WjupgrcWiaiaibFaianxnw9HpHMWSn1Sicd1LA4QLxCMZsMgFianicX32fDCTtJdeyjuWBLg/132, createdBy=b6d02007865, createdName=Dr. Du, createdTime=Mon Aug 13 18:45:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127214, encodeId=2b75212e21430, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：纳米递送系统;动物实验;牙周炎 经验分享：开始投的Int J Pharmaceutics，被transfer到EJPS，前期审稿速度有点慢，8周将近2个月才返回一审意见，两个评审人提了很多问题，一一回答，还驳斥了一条建议（现在想想自己胆子真大），好在退修后速度就一路做火箭，从退修给编辑再到录用见刊2周完成。还是很推荐认真做实验的硕博士投稿的，主编很nice，虽然影响因子一般，但医学2区还是很值，祝大家投稿顺利，成果早日发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5102337243, createdName=12282116m72暂无昵称, createdTime=Thu Apr 20 10:13:58 CST 2023, time=2023-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=528171, encodeId=4cfb5281e11b, content=审稿意见回来了吗？大卫的 2016-09-13 发表:: 研究方向：药代动力学;; 刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, beContent=大卫的 2016-09-13 发表:: 研究方向：药代动力学;; 刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Thu Oct 13 08:41:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536798, encodeId=80ac536e983f, content=投稿命中率:50.0 经验分享：刚被接受了一篇，就是第一次审稿的时候，耽误了太多时间，中间询问过一次。审稿结束后，几个小时就给了修改的决定。改后再次审稿后，又改了一次，就一个问题。投回去后，几个小时就接受了，这个杂志online速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2571742971, createdName=JYUZ, createdTime=Wed May 17 10:53:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563173, encodeId=3e555631e3ff, content=没有版面费173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗？谢谢, beContent=173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Wed Nov 14 00:00:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858485, encodeId=7fee85848558, content=从刚投稿到一审结束总共花了3个半月，提了不少问题，花了将近一个月修改返回，然后审稿花了一个月接收，从投到在线总共花了差不多半年。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Tue Mar 17 13:17:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222775, encodeId=bb4c1222e750c, content=一修的时候更换的共同一作中的一个，直接因更换作者被拒了，还有救吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cdf5458328, createdName=金鱼的眼泪, createdTime=Fri May 27 12:12:31 CST 2022, time=2022-05-27, status=1, ipAttribution=)]

2018-11-14 rongshi56

没有版面费173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表:
请问该杂志的版面费贵吗？谢谢

173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗？谢谢

337 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207167, encodeId=8650220e1672f, content=投稿链接是什么，为啥我打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28bc9231086, createdName=ms5000000002868146, createdTime=Tue May 28 22:44:38 CST 2024, time=2024-05-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180130, encodeId=bbb8218013085, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一篇新化合物+药理学研究的稿子，从投稿到接收共三个月，审稿很快。因审稿人问的问题非常专业，回复+补充数据时间花费了一个半月左右。还经历了二修，也修改了整整一个星期，这再次提升了我们稿子的质量，非常感谢这么专业的审稿人。二修返回第二天立马接收，效率杠杠的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Mon Jan 08 22:11:23 CST 2024, time=2024-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173349, encodeId=557321e3349b0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：药理学 经验分享：10分钟秒拒哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85938247141, createdName=ms2000002084293332, createdTime=Wed Dec 06 20:00:30 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560071, encodeId=0c8c5600e1c1, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：一篇新化合物+药理的稿子，觉得投欧洲药理，有点亏。就试了EJPS，从投稿到接收4个多月，审稿人很专业，我服气。总体感觉杂志很不错，绝对不是水刊，想灌水的可能到时会浪费时间。编辑友好！值得推荐给真才实学的人投稿！祝福大家，好运！我争取以后每中一篇文章就来medsci写个评论！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAxm7OEiaSP1WjupgrcWiaiaibFaianxnw9HpHMWSn1Sicd1LA4QLxCMZsMgFianicX32fDCTtJdeyjuWBLg/132, createdBy=b6d02007865, createdName=Dr. Du, createdTime=Mon Aug 13 18:45:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127214, encodeId=2b75212e21430, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：纳米递送系统;动物实验;牙周炎 经验分享：开始投的Int J Pharmaceutics，被transfer到EJPS，前期审稿速度有点慢，8周将近2个月才返回一审意见，两个评审人提了很多问题，一一回答，还驳斥了一条建议（现在想想自己胆子真大），好在退修后速度就一路做火箭，从退修给编辑再到录用见刊2周完成。还是很推荐认真做实验的硕博士投稿的，主编很nice，虽然影响因子一般，但医学2区还是很值，祝大家投稿顺利，成果早日发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5102337243, createdName=12282116m72暂无昵称, createdTime=Thu Apr 20 10:13:58 CST 2023, time=2023-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=528171, encodeId=4cfb5281e11b, content=审稿意见回来了吗？大卫的 2016-09-13 发表:: 研究方向：药代动力学;; 刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, beContent=大卫的 2016-09-13 发表:: 研究方向：药代动力学;; 刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Thu Oct 13 08:41:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536798, encodeId=80ac536e983f, content=投稿命中率:50.0 经验分享：刚被接受了一篇，就是第一次审稿的时候，耽误了太多时间，中间询问过一次。审稿结束后，几个小时就给了修改的决定。改后再次审稿后，又改了一次，就一个问题。投回去后，几个小时就接受了，这个杂志online速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2571742971, createdName=JYUZ, createdTime=Wed May 17 10:53:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563173, encodeId=3e555631e3ff, content=没有版面费173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗？谢谢, beContent=173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Wed Nov 14 00:00:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858485, encodeId=7fee85848558, content=从刚投稿到一审结束总共花了3个半月，提了不少问题，花了将近一个月修改返回，然后审稿花了一个月接收，从投到在线总共花了差不多半年。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Tue Mar 17 13:17:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222775, encodeId=bb4c1222e750c, content=一修的时候更换的共同一作中的一个，直接因更换作者被拒了，还有救吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cdf5458328, createdName=金鱼的眼泪, createdTime=Fri May 27 12:12:31 CST 2022, time=2022-05-27, status=1, ipAttribution=)]

2020-03-17 ms2798897682501839

从刚投稿到一审结束总共花了3个半月，提了不少问题，花了将近一个月修改返回，然后审稿花了一个月接收，从投到在线总共花了差不多半年。

247 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207167, encodeId=8650220e1672f, content=投稿链接是什么，为啥我打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28bc9231086, createdName=ms5000000002868146, createdTime=Tue May 28 22:44:38 CST 2024, time=2024-05-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180130, encodeId=bbb8218013085, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：一篇新化合物+药理学研究的稿子，从投稿到接收共三个月，审稿很快。因审稿人问的问题非常专业，回复+补充数据时间花费了一个半月左右。还经历了二修，也修改了整整一个星期，这再次提升了我们稿子的质量，非常感谢这么专业的审稿人。二修返回第二天立马接收，效率杠杠的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Mon Jan 08 22:11:23 CST 2024, time=2024-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173349, encodeId=557321e3349b0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：药理学 经验分享：10分钟秒拒哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85938247141, createdName=ms2000002084293332, createdTime=Wed Dec 06 20:00:30 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560071, encodeId=0c8c5600e1c1, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：一篇新化合物+药理的稿子，觉得投欧洲药理，有点亏。就试了EJPS，从投稿到接收4个多月，审稿人很专业，我服气。总体感觉杂志很不错，绝对不是水刊，想灌水的可能到时会浪费时间。编辑友好！值得推荐给真才实学的人投稿！祝福大家，好运！我争取以后每中一篇文章就来medsci写个评论！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=341, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAxm7OEiaSP1WjupgrcWiaiaibFaianxnw9HpHMWSn1Sicd1LA4QLxCMZsMgFianicX32fDCTtJdeyjuWBLg/132, createdBy=b6d02007865, createdName=Dr. Du, createdTime=Mon Aug 13 18:45:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127214, encodeId=2b75212e21430, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：纳米递送系统;动物实验;牙周炎 经验分享：开始投的Int J Pharmaceutics，被transfer到EJPS，前期审稿速度有点慢，8周将近2个月才返回一审意见，两个评审人提了很多问题，一一回答，还驳斥了一条建议（现在想想自己胆子真大），好在退修后速度就一路做火箭，从退修给编辑再到录用见刊2周完成。还是很推荐认真做实验的硕博士投稿的，主编很nice，虽然影响因子一般，但医学2区还是很值，祝大家投稿顺利，成果早日发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5102337243, createdName=12282116m72暂无昵称, createdTime=Thu Apr 20 10:13:58 CST 2023, time=2023-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=528171, encodeId=4cfb5281e11b, content=审稿意见回来了吗？大卫的 2016-09-13 发表:: 研究方向：药代动力学;; 刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, beContent=大卫的 2016-09-13 发表:: 研究方向：药代动力学;; 刚投了这期刊，withe editor时间为一轴，现在正在审稿，现在很忐忑，希望能被接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=511, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Thu Oct 13 08:41:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536798, encodeId=80ac536e983f, content=投稿命中率:50.0 经验分享：刚被接受了一篇，就是第一次审稿的时候，耽误了太多时间，中间询问过一次。审稿结束后，几个小时就给了修改的决定。改后再次审稿后，又改了一次，就一个问题。投回去后，几个小时就接受了，这个杂志online速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=432, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2571742971, createdName=JYUZ, createdTime=Wed May 17 10:53:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563173, encodeId=3e555631e3ff, content=没有版面费173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗？谢谢, beContent=173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Wed Nov 14 00:00:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858485, encodeId=7fee85848558, content=从刚投稿到一审结束总共花了3个半月，提了不少问题，花了将近一个月修改返回，然后审稿花了一个月接收，从投到在线总共花了差不多半年。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Tue Mar 17 13:17:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222775, encodeId=bb4c1222e750c, content=一修的时候更换的共同一作中的一个，直接因更换作者被拒了，还有救吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cdf5458328, createdName=金鱼的眼泪, createdTime=Fri May 27 12:12:31 CST 2022, time=2022-05-27, status=1, ipAttribution=)]

2022-05-27 金鱼的眼泪

一修的时候更换的共同一作中的一个，直接因更换作者被拒了，还有救吗

166 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务